Adjuvant radiotherapy to sites of previous bulky disease in patients stage iv diffuse large cell lymphoma

International Journal of Radiation Oncology, Biology, Physics

Volumn 30, Issue 4, 1994, Pages 799-803

  Avilés, Agustin ^a   Delgado, Serafin ^b   Nambo, M Jesus ^a   Alatriste, Sara ^c   Díaz Maqueo, JoséC ^a  

^a National Medical Center   (Mexico)

^b Radiotherapy National Medical Center ^*  (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Bulky disease; Chemotherapy; Malignant lymphoma; NonHodgkin's lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; EPIRUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; PROSPECTIVE STUDIES; VINCRISTINE; VINDESINE;

EID: 0028062747     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)90352-2     Document Type: Article

References (20)

1. Valoración de la función ventricular en pacientes tratados con mitoxantrona y epirubicina
2. Group-risk non Hodgkin's lymphoma
3. Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma
4. The role of maintenance therapy in diffuse large cell lymphoma
5. Beta 2 Microglobulin Level as an Indicator of Prognosis in Diffuse Large Cell Lymphoma
6. Prognostic factors in aggressive malignant lymphoma. Description and validation of a prognostic index that could identify patients requiring a more intensive therapy
7. Report of the first workshop of prognostic factors in large cell lymphoma
8. An alternating chemotherapy and radiotherapy combination for nonHodgkin's lymphoma of unfavourable histologies. Feasibility and preliminary results
9. Regression models and life tables
10. A generalized Wilcoxon's test for comparing arbitrarily single censored samples
11. Nonparametric Estimation from Incomplete Observations
12. Impact of second malignancy risk of the combined use of radiation and chemotherapy for lymphomas
13. The integration of radiotherapy into the primary treatment of nonHodgkin's lymphoma
14. Chemotherapy followed by consolidation radiation therapy for the treatment of clinical Stages II aggressive histologic type nonHodgkin's lymphoma
15. Stage I and II nonHodgkin's lymphoma. Long term results of radiation therapy
16. Patterns of relapse in large cell lymphoma patients with bulk disease. Implications for the use of adjuvant radiation therapy
17. The nonHodgkin's lymphoma pathological classification project: National Cancer Institute sponsored study of classification of nonHodgkin's lymphoma
18. Effective salvage therapy for lymphoma with cisplatin combination with high dose Ara C and dexamethasone (DHAP)
19. Stages I and II diffuse large cell lymphoma. Prognostic factors and long-term results with CHOP-Bleo and radiotherapy
20. The management of high-grade non Hodgkin's lymphomas